Tejon Ranch Co.
NYSE:TRCConglomerates
-$0.06 today
- Market cap
- $465.26M
- Beta
- 0.59
- P/E (TTM)
- 296.5
- EPS (TTM)
- $0.06
Volume 0.26M
Average 0.09M
TRC Total Non-current Liabilities
All obligations due after more than one year.
Tejon Ranch Co.NYSE: TRC
Total Non-current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total non-current liabilities rises 20.6% from a year ago
Total non-current liabilities stood at $132.21M at the end of Q1 FY2026, up 20.6% from a year earlier and up 1.4% from the prior quarter. Over 3 fiscal years it compounded at +19.1% a year.
Context
- Total non-current liabilities amounted to 20.8% of total assets at the end of Q1 FY2026, up 3.0 pp from a year earlier.
- Total non-current liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total non-current liabilities keeps rising in the next quarterly balance sheet after a +20.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 130.42M USD
- Year-over-year change
- +27.6%
- 4-year CAGR
- +15.2%
| Period | Period end | Total Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 130.42M | +27.6% |
| FY2024 | 2024-12-31 | 102.25M | +23.4% |
| FY2023 | 2023-12-31 | 82.87M | +7.4% |
| FY2022 | 2022-12-31 | 77.17M | +4.4% |
| FY2021 | 2021-12-31 | 73.93M | — |
Total Non-current Liabilities vs competitors
How TRC compares with its peers on the latest reported figures
- Peers report in different currencies, so total non-current liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +20.6% is the 4th highest of 10, against a peer median of -9.7%.
- Total non-current liabilities amounts to 20.8% of total assets for TRC, versus a peer median of 14.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $2.09B USD | +563.0% | +0.1% | 70.7% | |
| Apr 2026 | $868.06M USD | +5.2% | +24.8% | 50.3% | |
| Mar 2026 | $193.24M USD | -9.7% | +31.6% | 26.7% | |
| Mar 2026 | $132.21M USD | +20.6% | +19.1% | 20.8% | |
| Mar 2026 | $126.85M USD | +76.6% | +8.8% | 26.5% | |
| Apr 2026 | $60.84M USD | -49.5% | -4.3% | 11.9% | |
SRTAStrata Critical Medical, Inc. | Mar 2026 | $20.95M USD | +134.4% | +3.6% | 6.4% |
| Mar 2026 | $16.93M USD | -18.6% | -15.7% | 2.7% | |
| Mar 2026 | $9.26M USD | -69.7% | -18.6% | 14.8% | |
| Mar 2026 | £2.96M GBP | -61.5% | -21.7% | 2.5% | |
| Peer median (excluding TRC) | — | -9.7% | +0.1% | 14.8% | |
Competitors are the stored peer set for TRC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 36.2M | 39.12M | 31.91M | 39.27M | 9.52M |
| Short-term Investments | 10.98M | 33.44M | 32.56M | 14.44M | 15.37M |
| Net Receivables | 6.53M | 4.45M | 8.35M | 7.92M | 9.39M |
| Inventory | 5.7M | 3.37M | 3.49M | 3.97M | 3.35M |
| Other Current Assets | 3.57M | 2.66M | 3.5M | 3.81M | 1.63M |
| Total Current Assets | 62.97M | 83.05M | 79.81M | 69.4M | 39.26M |
| Property, Plant & Equipment (Net) | 50.7M | 52.98M | 53.99M | 56.39M | 59.31M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 51M | 47.05M | 52.13M | 19.01M | 62.59M |
| Long-term Investments | 43.42M | 41.89M | 33.65M | 65.06M | 29.99M |
| Tax Assets | 336.33M | 9.78M | 0 | 0 | 0 |
| Other Non-current Assets | 1.62M | 332.05M | 357.95M | 398.14M | 439.32M |
| Total Non-current Assets | 483.06M | 483.75M | 497.71M | 538.6M | 591.21M |
| Total Assets | 546.04M | 566.79M | 577.52M | 608M | 630.47M |
| Account Payables | 4.55M | 5.12M | 6.46M | 9.09M | 5.24M |
| Short-term Debt | 4.48M | 1.78M | 0 | 0 | 0 |
| Tax Payables | 1.22M | 0 | 0 | 0 | 0 |
| Deferred Revenue | 1.91M | 1.53M | 1.89M | 2.16M | 2.06M |
| Other Current Liabilities | 251K | 239K | 286K | 5.26M | 1.76M |
| Total Current Liabilities | 15.6M | 12.03M | 11.56M | 16.8M | 9.49M |
| Long-term Debt | 48.16M | 48.16M | 47.94M | 66.94M | 93.94M |
| Deferred Tax Liabilities | 2.9M | 7.18M | 8.27M | 9.06M | 9.85M |
| Deferred Revenue (Non-current) | 8.41M | 11.45M | 11.45M | 11.45M | 10.94M |
| Other Non-current Liabilities | 14.47M | 10.38M | 15.21M | 14.8M | 15.7M |
| Total Non-current Liabilities | 73.93M | 77.17M | 82.87M | 102.25M | 130.42M |
| Total Liabilities | 89.53M | 89.2M | 94.43M | 119.04M | 139.91M |
| Common Stock | 13.2M | 13.27M | 13.39M | 13.41M | 13.46M |
| Retained Earnings | 89.84M | 105.64M | 108.91M | 111.6M | 111.67M |
| Accumulated OCI | (6.82M) | (2.03M) | (171K) | 87K | (177K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 15.36M | 15.36M | 15.36M | 15.36M | 15.36M |
| Total Equity | 456.51M | 477.59M | 483.1M | 488.96M | 490.56M |
| Total Debt | 52.63M | 49.94M | 47.94M | 66.94M | 93.94M |
| Net Debt | 16.44M | 10.82M | 16.04M | 27.68M | 84.42M |
Tejon Ranch Co.
NYSE:TRC
Intrinsic Alpha fair value
Locked
Current Price
$17.21
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.